Literature DB >> 620225

Familial thrombosis: inherited deficiency of antithrombin III.

M Mackie, B Bennett, D Ogston, A S Douglas.   

Abstract

Several members of a family living on the west coast of Scotland and on one of the islands off the coast had serious thrombotic disease. The plasma antithrombin III (ATIII) concentrations were measured by both functional and immunological assay in all available members of the family. Concentrations were 25% to 66% of normal in 12 people, including all seven with thrombotic disease. The inheritance pattern was characteristic of an autosomal dominant disorder. Thrombotic disease generally affected the leg, mesenteric, and axillary veins, although one man who had died before the study began had had severe arterial atheroma. In women the first thrombotic symptoms usually occurred during pregnancy. None of these patients have developed thrombotic symptoms until they were at least 18, so four younger members of the family who have ATIII deficiency but no thrombotic disease may eventually develop symptoms.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 620225      PMCID: PMC1602800          DOI: 10.1136/bmj.1.6106.136

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  23 in total

1.  INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.

Authors:  O EGEBERG
Journal:  Thromb Diath Haemorrh       Date:  1965-06-15

2.  The plasmin inhibitor of human plasma. IV. Its action on plasmin, trypsin, chymotrypsin, and thrombin.

Authors:  A Rimon; Y Shamash; B Shapiro
Journal:  J Biol Chem       Date:  1966-11-10       Impact factor: 5.157

3.  Identity of plasma-activated factor X inhibitor with antithrombin 3 and heparin cofactor.

Authors:  E T Yin; S Wessler; P J Stoll
Journal:  J Biol Chem       Date:  1971-06-10       Impact factor: 5.157

4.  Oral contraceptives and low antithrombin-3 activity.

Authors:  E von Kaulla; K N von Kaulla
Journal:  Lancet       Date:  1970-01-03       Impact factor: 79.321

5.  Assay of progressive antithrombin in plasma.

Authors:  U Abildgaard; K Gravem; H C Godal
Journal:  Thromb Diath Haemorrh       Date:  1970-10-31

6.  Antithrombin-3 deficiency in a Dutch family.

Authors:  J van der Meer; E A Stoepman-van Dalen; J M Jansen
Journal:  J Clin Pathol       Date:  1973-07       Impact factor: 3.411

7.  Hereditary antithrombin III deficiency and thromboembolic disease.

Authors:  D J Filip; J D Eckstein; J J Veltkamp
Journal:  Am J Hematol       Date:  1976       Impact factor: 10.047

8.  Oral contraceptives, antithrombin- III activity, and postoperative deep-vein thrombosis.

Authors:  S Sagar; J D Stamatakis; D P Thomas; V V Kakkar
Journal:  Lancet       Date:  1976-03-06       Impact factor: 79.321

9.  Antifactor Xa activity in thrombophilia. Studies in a family with Ar-III deficiency.

Authors:  O R Odegård; U Abildgaard
Journal:  Scand J Haematol       Date:  1977-02

10.  Prophylactic and therapeutic use of anticoagulants in inherited antithrombin III deficiency.

Authors:  M L Zucker; E D Gomperts; R G Marcus
Journal:  S Afr Med J       Date:  1976-10-09
View more
  14 in total

1.  Quite a backup: pericardial varices in a patient with hereditary antithrombin deficiency.

Authors:  Jason N Salamon; Santhosh Mannem; Mark Guelfguat
Journal:  Quant Imaging Med Surg       Date:  2013-06

2.  Risk associated with heparin withdrawal in ischaemic cerebrovascular disease.

Authors:  A Slivka; D E Levy; R H Lapinski
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-12       Impact factor: 10.154

3.  Associated von Willebrand disease as a possible cause of lack of thrombosis in an AT III abnormality (AT III Trento).

Authors:  A Girolami; M G Cappellato; M A Vicarioto; S Casonato; F Marafioti
Journal:  Blut       Date:  1986-01

4.  Evidence linking familial thrombosis with a defective antithrombin III gene in two British kindreds.

Authors:  S H Sacks; J M Old; S T Reeders; D J Weatherall; A S Douglas; J H Winter; C R Rizza
Journal:  J Med Genet       Date:  1988-01       Impact factor: 6.318

Review 5.  Mechanisms of deep vein thrombosis: a review.

Authors:  M Brozović
Journal:  J R Soc Med       Date:  1979-08       Impact factor: 5.344

6.  Venography in axillary-subclavian vein thrombosis.

Authors:  E C Martin; M Koser; D H Gordon
Journal:  Cardiovasc Radiol       Date:  1979-11

Review 7.  Familial venous thrombosis.

Authors:  J H Winter; A S Douglas
Journal:  Postgrad Med J       Date:  1983-11       Impact factor: 2.401

8.  Antithrombin III deficiency in ischaemic stroke.

Authors:  V Hossmann; W D Heiss; H Bewermeyer
Journal:  Klin Wochenschr       Date:  1983-06-15

9.  Antithrombin III (AT III) Padua2: a "new" congenital abnormality with defective heparin co-factor activities but no thrombotic disease.

Authors:  A Girolami; F Fabris; G Cappellato; L Sainati; G Boeri
Journal:  Blut       Date:  1983-08

10.  Relation between antithrombin III and clinical and serological parameters in systemic lupus erythematosus.

Authors:  M P Jarrett; D Green; C H Ts'ao
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.